IL2 and Autoimmunity: However, recent research has suggested that the modulation of the Foxp3+ regulatory T-cells (Tregs) and the use of cytokine therapy with IL-2 (NCT02772679) may partially prevent ßeta-cell autoimmunity [37,38].